Search research articles
Contact Us
Filters
Showing results (61-70 of 428) with videos related to
Page
of 43
Sort By:
International Journal of Chronic Obstructive Pulmonary Disease
|
March 19, 2019
Extrafine triple therapy delays COPD clinically important deterioration vs ICS/LABA, LAMA, or LABA/LAMA
Dave Singh, Leonardo M Fabbri, Stefano Vezzoli, et al.
Contributions to Microbiology
|
August 9, 2007
A human rhinovirus model of chronic obstructive pulmonary disease exacerbations
Marco Contoli, Gaetano Caramori, Patrick Mallia, et al.
Therapeutics and Clinical Risk Management
|
February 12, 2009
Beclomethasone/formoterol fixed combination for the management of asthma: patient considerations
Gabriele Nicolini, Nicola Scichilone, Andrea Bizzi, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
November 28, 2020
As-needed anti-inflammatory reliever therapy for asthma management: evidence and practical considerations
Andrea Bianco, Marco Contoli, Fabiano Di Marco, et al.
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace
|
October 18, 2016
Phenomenology of COPD: interpreting phenotypes with the ECLIPSE study
Alberto Papi, Maria Sandra Magnoni, Carmelo Caio Muzzio, et al.
Multidisciplinary Respiratory Medicine
|
September 18, 2024
An Italian Delphi Consensus on the Triple inhalation Therapy in Chronic Obstructive Pulmonary Disease
Paolo Solidoro, Federico Dente, Claudio Micheletto, et al.
Pathogens (Basel, Switzerland)
|
November 24, 2022
SARS-CoV-2 Infection Prompts IL-1β-Mediated Inflammation and Reduces IFN-λ Expression in Human Lung Tissue
Bianca Vezzani, Margherita Neri, Stefano D'Errico, et al.
Current Drug Targets
|
December 22, 2012
Immune and genetic mechanisms in COPD: possible targets for therapeutic interventions
Eleni G Tzortzaki, Alberto Papi, Eirini Neofytou, et al.
Respiratory Medicine
|
August 7, 2013
Stepping down from high dose fluticasone/salmeterol to extrafine BDP/F in asthma is cost-effective
Pierluigi Paggiaro, Shishir Patel, Gabriele Nicolini, et al.
Frontiers in Pharmacology
|
December 10, 2021
Tanimilast, A Novel Inhaled Pde4 Inhibitor for the Treatment of Asthma and Chronic Obstructive Pulmonary Disease
Fabrizio Facchinetti, Maurizio Civelli, Dave Singh, et al.
Page
of 43
Search research articles
Search
Showing results (61-70 of 428) with videos related to
Sort By:
Page
of 43
International Journal of Chronic Obstructive Pulmonary Disease
|
March 19, 2019
Extrafine triple therapy delays COPD clinically important deterioration vs ICS/LABA, LAMA, or LABA/LAMA
Dave Singh, Leonardo M Fabbri, Stefano Vezzoli, et al.
Contributions to Microbiology
|
August 9, 2007
A human rhinovirus model of chronic obstructive pulmonary disease exacerbations
Marco Contoli, Gaetano Caramori, Patrick Mallia, et al.
Therapeutics and Clinical Risk Management
|
February 12, 2009
Beclomethasone/formoterol fixed combination for the management of asthma: patient considerations
Gabriele Nicolini, Nicola Scichilone, Andrea Bizzi, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
November 28, 2020
As-needed anti-inflammatory reliever therapy for asthma management: evidence and practical considerations
Andrea Bianco, Marco Contoli, Fabiano Di Marco, et al.
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace
|
October 18, 2016
Phenomenology of COPD: interpreting phenotypes with the ECLIPSE study
Alberto Papi, Maria Sandra Magnoni, Carmelo Caio Muzzio, et al.
Multidisciplinary Respiratory Medicine
|
September 18, 2024
An Italian Delphi Consensus on the Triple inhalation Therapy in Chronic Obstructive Pulmonary Disease
Paolo Solidoro, Federico Dente, Claudio Micheletto, et al.
Pathogens (Basel, Switzerland)
|
November 24, 2022
SARS-CoV-2 Infection Prompts IL-1β-Mediated Inflammation and Reduces IFN-λ Expression in Human Lung Tissue
Bianca Vezzani, Margherita Neri, Stefano D'Errico, et al.
Current Drug Targets
|
December 22, 2012
Immune and genetic mechanisms in COPD: possible targets for therapeutic interventions
Eleni G Tzortzaki, Alberto Papi, Eirini Neofytou, et al.
Respiratory Medicine
|
August 7, 2013
Stepping down from high dose fluticasone/salmeterol to extrafine BDP/F in asthma is cost-effective
Pierluigi Paggiaro, Shishir Patel, Gabriele Nicolini, et al.
Frontiers in Pharmacology
|
December 10, 2021
Tanimilast, A Novel Inhaled Pde4 Inhibitor for the Treatment of Asthma and Chronic Obstructive Pulmonary Disease
Fabrizio Facchinetti, Maurizio Civelli, Dave Singh, et al.
Page
of 43